---
layout: post
title: "Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations"
date: 2026-02-05 18:53:12 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2024-00886
original_published: 2024-01-18 00:00:00 +0000
significance: 8.00
---

# Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations

**Published:** February 05, 2026 18:53 UTC
**Source:** Federal Register
**Original Published:** January 18, 2024 00:00 UTC
**Document Number:** 2024-00886

## Summary

The Food and Drug Administration (FDA or Agency) is announcing that a collection of information entitled "Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2024/01/18/2024-00886/agency-information-collection-activities-announcement-of-office-of-management-and-budget-approval)
- API: https://www.federalregister.gov/api/v1/documents/2024-00886

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
